Multiplex immunohistochemistry analysis of CTLA4, PD-L1, LAG3 and tumour microenvironment components in relation to MMR status in colorectal carcinoma

被引：0
|
作者：
Naumov, S. [1 ]
Krakhmal, N. [1 ]
Vtorushin, S. [1 ]
机构：
[1] Siberian State Med Univ, Tomsk, Russia
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-24-027
引用
收藏
页码：S157 / S158
页数：2
相关论文
共 50 条
  • [31] Quantitative Analysis of the Head and Neck Squamous Cell Carcinoma Tumor Microenvironment and Correlation with PD-L1 Immunohistochemistry Using a Novel Multiplexed Immunofluorescence Assay
    Wong, Kristine
    Jo, Vickie
    Nowak, Jonathan
    Rodig, Scott
    Lindeman, Neal
    Sholl, Lynette
    Felt, Kristen
    Hanna, Glenn
    Lindsay, James
    Kumari, Priti
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1239 - 1240
  • [32] Quantitative Analysis of the Head and Neck Squamous Cell Carcinoma Tumor Microenvironment and Correlation with PD-L1 Immunohistochemistry Using a Novel Multiplexed Immunofluorescence Assay
    Wong, Kristine
    Jo, Vickie
    Nowak, Jonathan
    Rodig, Scott
    Lindeman, Neal
    Sholl, Lynette
    Felt, Kristen
    Hanna, Glenn
    Lindsay, James
    Kumari, Priti
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1239 - 1240
  • [33] An immunohistochemical analysis of CD3, PD-L1, and CTLA-4 expression in carcinosarcomas of the gynecological tract and their metastases
    Karpathiou, Georgia
    Chauleur, Celine
    Dal Col, Pierre
    Dridi, Maroa
    Hathroubi, Sirine
    Mobarki, Mousa
    Peoc'h, Michel
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (08)
  • [34] Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
    Saleh, Reem
    Toor, Salman M.
    Khalaf, Sarah
    Elkord, Eyad
    VACCINES, 2019, 7 (04)
  • [35] Altered expression of TIM-3, LAG-3, IDO, PD-L1, and CTLA-4 during nimotuzumab therapy correlates with responses and prognosis of oral squamous cell carcinoma patients
    Wang, Hong
    Mao, Lu
    Zhang, Tian
    Zhang, Liming
    Wu, Yuteng
    Guo, Wei
    Hu, Jingzhou
    Ju, Houyu
    Ren, Guoxin
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2019, 48 (08) : 669 - 676
  • [36] Comparative Analysis of PD-1, PD-L1 and CTLA-4 Expression in Infiltrating Leukocytes in Tumor Tissue and Peripheral Blood in Patients with Renal Cell Carcinoma
    Garza, Raquel Gonzalez
    Carmona, Mario Salinas
    Gonzalez, Adrian Gutierrez
    Gutierrez, Juan Flores
    Corona, Maria Castro
    Torres, Manuel Mejia
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [37] Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of advanced colorectal cancer: a systematic review and meta-analysis
    Song, Dandan
    Hou, Shufu
    Ma, Ning
    Yan, Bing
    Gao, Jing
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [38] Multiplex Immuno-Liquid Chromatography-Mass Spectrometry-Parallel Reaction Monitoring (LC-MS-PRM) Quantitation of CD8A, CD4, LAG3, PD1, PD-L1, and PD-L2 in Frozen Human Tissues
    Zhang, Qian
    Salzler, Robert
    Dore, Anthony
    Yang, Janice
    Ma, Dangshe
    Olson, William C.
    Liu, Yashu
    JOURNAL OF PROTEOME RESEARCH, 2018, 17 (11) : 3932 - 3940
  • [39] DIFFERENTIAL EXPRESSION OF PD-L1, PD1 AND CTLA4 RECEPTOR ACCORDING TO HISTOLOGY AND TUMOUR VS. SURROUNDING NON-MALIGNANT LUNG TISSUE IN NON-SMALL CELL LUNG CANCER: RNA SEQUENCING DATA
    De Ruysscher, Dirk
    Wauters, Els
    Reynders, Kobe
    Vansteenkiste, Johan
    Decaluwe, Herbert
    De Leyn, Paul
    Nackaerts, Kristiaan
    Peeters, Stephanie
    Dooms, Christophe
    Janssens, Wim
    Lambrechts, Diether
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S765 - S765
  • [40] Expression of Programmed Cell-Death Ligand 1 (PD-L1) and Analysis of Microsatellite Instability/ DNA Mismatch Repair (MSI/MMR) Status in Penile Squamous Cell Carcinoma (PC)
    Das, Debasmita
    Indulkar, Shreeya
    Krishna, Mohan
    Rao, B. Vishal
    Kodandapani, Suseela
    Sharma, Rakesh
    Rao, T.
    LABORATORY INVESTIGATION, 2023, 103 (03) : S707 - S708
12345